Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Toxicology Reports
|
May 14, 2019
Toxicity and pharmacokinetic profile of SGM-101, a fluorescent anti-CEA chimeric antibody for fluorescence imaging of tumors in patients
Bérénice Framery, Marian Gutowski, Karen Dumas, et al.
Frontiers in Psychiatry
|
July 8, 2022
Feasibility of Online High-Intensity Interval Training (HIIT) on Psychological Symptoms in Students in Lockdown During the COVID-19 Pandemic: A Randomized Controlled Trial
Arnaud Philippot, Pauline Moulin, Marie-Hélène Charon, et al.
Data in Brief
|
May 2, 2022
Data on the impact of physical exercise treatment on depression and anxiety in a psychiatric hospital for adolescents
Arnaud Philippot, Vincent Dubois, Kate Lambrechts, et al.
Journal of Medicinal Chemistry
|
December 13, 2006
Improved therapeutic efficacy of doxorubicin through conjugation with a novel peptide drug delivery technology (Vectocell)
Florence Meyer-Losic, Jérôme Quinonero, Vincent Dubois, et al.
Journal of Affective Disorders
|
January 10, 2022
Impact of physical exercise on depression and anxiety in adolescent inpatients: A randomized controlled trial
Arnaud Philippot, Vincent Dubois, Kate Lambrechts, et al.
British Journal of Clinical Pharmacology
|
August 20, 2021
Concentration-QT modelling in early clinical oncology settings: Simulation evaluation of performance
Gael Cantet, Alienor Berges, Rhianna O'Sullivan, et al.
BMJ Open Ophthalmology
|
October 2, 2024
Comparative outcomes of selective laser trabeculoplasty delivered by optometrists compared with ophthalmologists: a UK-based multicentre observational study
Chan Ning Lee, Alexander Delaney, Jay A L Richardson, et al.
Clinical Drug Investigation
|
January 5, 2013
Improving treatment adherence in your patients with schizophrenia: the STAY initiative
Fernando Cañas, Koksal Alptekin, Jean Michel Azorin, et al.
Cancer Research
|
April 17, 2002
CPI-0004Na, a new extracellularly tumor-activated prodrug of doxorubicin: in vivo toxicity, activity, and tissue distribution confirm tumor cell selectivity
Vincent Dubois, Luc Dasnois, Karim Lebtahi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 19, 2008
Preclinical toxicity, toxicokinetics, and antitumoral efficacy studies of DTS-201, a tumor-selective peptidic prodrug of doxorubicin
Denis Ravel, Vincent Dubois, Jérôme Quinonero, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Toxicology Reports
|
May 14, 2019
Toxicity and pharmacokinetic profile of SGM-101, a fluorescent anti-CEA chimeric antibody for fluorescence imaging of tumors in patients
Bérénice Framery, Marian Gutowski, Karen Dumas, et al.
Frontiers in Psychiatry
|
July 8, 2022
Feasibility of Online High-Intensity Interval Training (HIIT) on Psychological Symptoms in Students in Lockdown During the COVID-19 Pandemic: A Randomized Controlled Trial
Arnaud Philippot, Pauline Moulin, Marie-Hélène Charon, et al.
Data in Brief
|
May 2, 2022
Data on the impact of physical exercise treatment on depression and anxiety in a psychiatric hospital for adolescents
Arnaud Philippot, Vincent Dubois, Kate Lambrechts, et al.
Journal of Medicinal Chemistry
|
December 13, 2006
Improved therapeutic efficacy of doxorubicin through conjugation with a novel peptide drug delivery technology (Vectocell)
Florence Meyer-Losic, Jérôme Quinonero, Vincent Dubois, et al.
Journal of Affective Disorders
|
January 10, 2022
Impact of physical exercise on depression and anxiety in adolescent inpatients: A randomized controlled trial
Arnaud Philippot, Vincent Dubois, Kate Lambrechts, et al.
British Journal of Clinical Pharmacology
|
August 20, 2021
Concentration-QT modelling in early clinical oncology settings: Simulation evaluation of performance
Gael Cantet, Alienor Berges, Rhianna O'Sullivan, et al.
BMJ Open Ophthalmology
|
October 2, 2024
Comparative outcomes of selective laser trabeculoplasty delivered by optometrists compared with ophthalmologists: a UK-based multicentre observational study
Chan Ning Lee, Alexander Delaney, Jay A L Richardson, et al.
Clinical Drug Investigation
|
January 5, 2013
Improving treatment adherence in your patients with schizophrenia: the STAY initiative
Fernando Cañas, Koksal Alptekin, Jean Michel Azorin, et al.
Cancer Research
|
April 17, 2002
CPI-0004Na, a new extracellularly tumor-activated prodrug of doxorubicin: in vivo toxicity, activity, and tissue distribution confirm tumor cell selectivity
Vincent Dubois, Luc Dasnois, Karim Lebtahi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 19, 2008
Preclinical toxicity, toxicokinetics, and antitumoral efficacy studies of DTS-201, a tumor-selective peptidic prodrug of doxorubicin
Denis Ravel, Vincent Dubois, Jérôme Quinonero, et al.
Page
of 5